The CDMO’s latest investment will boost capacity at its Charles City, IA facility by 40%, underscoring Cambrex’s focus on ...
The agency’s decision to conceal drug names on inspection reports has prevented doctors, pharmacists and patients from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback